The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,163,411 in first-year total cost, median $1,163,411.
Most frequent study sections
- Special Emphasis Panel[ZTR1 CI-6 (02)]1
Most frequent institutions
- ALLEGHENY-SINGER RESEARCH INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Anti-inflammatory Small Drug as Adjunctive Therapy to Improve Glucometabolic Variables in Obese, Insulin-Resistant Type 2 Diabetic Patients1UH3TR001372-01 | GIANNOUKAKIS, NICK | ALLEGHENY-SINGER RESEARCH INSTITUTE, PA | $1,163,411 | ZTR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.